Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: An underrecognized problem?

Journal of Clinical Psychiatry

Volumn 64, Issue 2, 2003, Pages 156-160

  Kanayama, Gen ^b   Cohane, Geoffrey H ^b   Weiss, Roger D ^b   Pope Jr , Harrison G ^a  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

ADULT; AGGRESSION; ALCOHOL ABUSE; ARTICLE; COCAINE DEPENDENCE; DRUG USE; DRUG WITHDRAWAL; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; RISK FACTOR; SUBSTANCE ABUSE; SUICIDE ATTEMPT; SYMPTOM; UNITED STATES; VIOLENCE;

EID: 0037328295     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0208     Document Type: Article

References (18)

1. Pope HG Jr, Brower KJ. Anabolic-androgenic steroid abuse. In: Sadock BJ. Sadock VA, eds. Comprehensive Textbook of Psychiatry/VII. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:1085-1095
2. Yesalis CE, Kennedy NJ, Kopstein AN, et al. Anabolic-androgenic steroid use in the United States. JAMA 1993;270:1217-1221
3. Pope HG, Phillips KA, Olivardia R. The Adonis Complex: How to Identify, Treat, and Prevent Body Obsession in Men and Boys. New York, NY: Simon & Schuster; 2002
4. Kanayama G, Pope HG Jr, Hudson JI. "Body image" drugs: a growing psychosomatic problem. Psychother Psychosom 2001;70:61-65
5. Su T-P, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993;269:2760-2764
6. Malone DA Jr, Dimeff R, Lombardo JA. et al. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sports Med 1995;5:25-31
7. Brower KJ, Blow FC, Beresford TP, et al. Anabolic-androgenic steroid dependence. J Clin Psychiatry 1989;50:31-33
8. McBride AJ, Williamson K, Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid abuse. Br J Sports Med 1996;30:69-70
9. Wines JD, Gruber AJ, Pope HG, et al. Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addict 1999;8:161-164
10. Arvary D, Pope HG. Anabolic-androgenic steroids as a gateway to opioid dependence [letter]. N Engl J Med 2000;342:1532
11. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. Arch Gen Psychiatry 1994;51:375-382
12. Clancy GP. Yates WR. Anabolic steroid use among substance abusers in treatment. J Clin Psychiatry 1992;53:97-100
13. Tennant F, Black DL, Voy RO. Anabolic steroid dependence with opioid-type features [letter]. N Engl J Med 1988;319:578
14. Kashkin KB, Kleber HD. Hooked on hormones? an anabolic steroid addiction hypothesis. JAMA 1989;262:3166-3170
15. Menard CS, Hebert TJ, Dohanich GP, et al. Androgenic-anabolic steroids modify β-endorphin immunoreactivity in the rat brain. Brain Res 1995;669:255-262
16. Johansson P, Ray A, Zhou Q, et al. Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci Res 1997;27:185-189
17. Harlan RE, Brown HE, Lynch CS, et al. Androgenic-anabolic steroids blunt morphine-induced c-fos expression in the rat striatum: possible role of β-endorphin. Brain Res 2000;853:99-104
18. Negus SS, Pope HG Jr, Kanayama G, et al. Lack of evidence of opioid tolerance or dependence in Rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology 2001;26:789-796